Angiology最新文献_第9页

Effect of Serum Bilirubin Levels on Contrast-induced Acute Kidney Injury: A Systematic Evaluation and Meta-analysis. 血清胆红素水平对造影剂引起的急性肾损伤的影响：系统评估与元分析》。

IF 2.8 3区医学

Angiology Pub Date : 2024-08-01 Epub Date: 2023-06-28 DOI: 10.1177/00033197231186493

Lin Lyu, Yuxin Miao, Xuequan Liu, He Dong, Haichen Chu, Xiaoyu Wang

{"title":"Effect of Serum Bilirubin Levels on Contrast-induced Acute Kidney Injury: A Systematic Evaluation and Meta-analysis.","authors":"Lin Lyu, Yuxin Miao, Xuequan Liu, He Dong, Haichen Chu, Xiaoyu Wang","doi":"10.1177/00033197231186493","DOIUrl":"10.1177/00033197231186493","url":null,"abstract":"Contrast-induced acute kidney injury (CI-AKI) is an important complication following the use of iodinated contrast media. Bilirubin has a protective effect but may also aggravate CI-AKI. The purpose of this systematic review was to assess whether bilirubin is a risk factor for CI-AKI. We searched the databases PubMed, Embase, Web of Science, Cochrane Library, Scopus, Ovid Medline, CNKI (China National Knowledge Infrastructure), VPCS (Vip Paper Check System), Wanfang, and CBM (Chinese BioMedical Literature Database) from the initial date to May 6, 2023. We summarized the results by directly combining the effect-size odds ratio (OR) and 95% confidence interval (CI) and identified sources of heterogeneity through subgroup analysis, sensitivity analysis, and meta-regression analysis. A total of 10 studies (14 data sets) were included: 7 retrospective studies (10 data sets) and 3 prospective studies (4 data sets), involving 12776 participants. The incidence of CI-AKI of 16% (95% CI: 14-19%). Total bilirubin was positively associated with the occurrence of CI-AKI (OR = 1.80; 95% CI: 1.36-2.38). Both low and high bilirubin concentrations were risk factors for CI-AKI. The incidence of CI-AKI was higher in the low bilirubin group than in the high bilirubin group.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9695463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Effect of Sarcopenia on Coronary Atherosclerotic Burden, Lesion Complexity, and Major Cardiovascular Events in Elderly Patients With Acute Coronary Syndrome: A 1-year Follow-up Study. 肌肉疏松症对急性冠状动脉综合征老年患者冠状动脉粥样硬化负担、病变复杂性及主要心血管事件的影响：为期一年的随访研究

IF 2.8 3区医学

Angiology Pub Date : 2024-08-01 Epub Date: 2023-06-30 DOI: 10.1177/00033197231187230

Merve Erkan, İsmet Zengin, Süleyman Bekircavuşoğlu, Dursun Topal, Turhan Bulut, Hakan Erkan

{"title":"Effect of Sarcopenia on Coronary Atherosclerotic Burden, Lesion Complexity, and Major Cardiovascular Events in Elderly Patients With Acute Coronary Syndrome: A 1-year Follow-up Study.","authors":"Merve Erkan, İsmet Zengin, Süleyman Bekircavuşoğlu, Dursun Topal, Turhan Bulut, Hakan Erkan","doi":"10.1177/00033197231187230","DOIUrl":"10.1177/00033197231187230","url":null,"abstract":"Sarcopenia is accepted as an indicator of subclinical atherosclerosis. However, its effects on clinical coronary atherosclerotic burden and lesion complexity and major adverse cardiovascular events (MACE) in elderly patients with non-ST elevation myocardial infarction (NSTEMI) are unknown. Therefore, we evaluated these possible effects. Coronary artery disease (CAD) burden and complexity were assessed using the Gensini and TAXus and cardiac surgery (SYNTAX) score, respectively. MACE involving nonfatal myocardial infarction, rehospitalization, ischemic stroke, and total mortality were evaluated after 1 year of the index NSTEMI event. The study included 240 elderly patients; of these, 60 (25%) patients had sarcopenia. The SYNTAX score and Gensini score were similar in both groups (16.8 ± 8.7 vs 17.3 ± 9.2, P = .63 and 67.7 ± 43.9 vs 73.9 ± 45.5, P = .31, respectively). The total MACE rate was significantly higher in patients with sarcopenia than in those without sarcopenia (31.7 vs 14.4%, P = .003). In the multivariate model, age [odds ratio (OR) 1.112, 95% CI: 1.006-1.228, P = .04)], ejection fraction (OR: .923, 95% CI: .897-.951, P < .001), and sarcopenia (OR: 2.262, 95% CI: 1.039-4.924, P = .04) were independently associated with MACE. Sarcopenia was independently associated with MACE but not with CAD burden or complexity in elderly patients with NSTEMI.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9690187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Letter: The Value of Systemic-Immune Inflammatory Response Index in Predicting Contrast-Induced Nephropathy in Patients With ST-Elevation Myocardial Infarction. 信全身免疫炎症反应指数在预测 ST 段抬高型心肌梗死患者对比度诱发肾病中的价值

IF 2.8 3区医学

Angiology Pub Date : 2024-08-01 Epub Date: 2023-09-06 DOI: 10.1177/00033197231201924

De-Gang Mo

引用次数: 0

Prognostic Nutritional Index as a Predictor of No-Reflow Occurrence in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention. 预后营养指数作为接受原发性经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者无回流发生率的预测指标。

IF 2.8 3区医学

Angiology Pub Date : 2024-08-01 Epub Date: 2023-08-08 DOI: 10.1177/00033197231193223

Ozgen Safak, Tarik Yildirim, Volkan Emren, Eyup Avci, Onur Argan, Zihni Aktas, Seda Elcim Yildirim, Didar Elif Akgun, Halil Lutfi Kisacik

{"title":"Prognostic Nutritional Index as a Predictor of No-Reflow Occurrence in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.","authors":"Ozgen Safak, Tarik Yildirim, Volkan Emren, Eyup Avci, Onur Argan, Zihni Aktas, Seda Elcim Yildirim, Didar Elif Akgun, Halil Lutfi Kisacik","doi":"10.1177/00033197231193223","DOIUrl":"10.1177/00033197231193223","url":null,"abstract":"Nutritional status and its index (Prognostic Nutritional Index, PNI) is an important prognostic factor for ST-segment elevation myocardial infarction (STEMI). The present study investigated whether PNI it is associated with no-reflow in patients with STEMI. In this retrospective study, 404 patients with STEMI and underwent primary percutaneous coronary intervention (pPCI) were consecutively included, between January 2016 and December 2018. No-reflow phenomenon (NRP) was detected in 103 (25.4%) patients. In multivariate logistic regression analysis C-reactive protein (CRP) (odds ratio (OR): 1.693, 95% confidence interval (CI): 1.126-2.547, P = .011), left ventricle ejection fraction (LVEF) (OR: 0.777, 95% CI: 0.678-0.891, P < .001), SYNTAX score (OR: 1.114, 95% CI: 1.050-1.183, P = .001), low density lipoprotein cholesterol (LDL-C) (OR: 1.033, 95% CI: 1.013-1.055, P = .002), hemoglobin level (OR: 0.572, 95% CI: 0.395-0.827, P = .003), PNI (OR: 0.554, 95% CI: 0.448-0.686, P < .001) were associated with NRP. The area under curve of PNI was significantly higher than albumin (z = 4.747, P < .001) and lymphocyte values (z = 3.481 P < .001). PNI was associated with no-reflow occurrence and mortality. So, PNI may be useful to predict NRP risk in patients with STEMI before pPCI.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9951069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Venous Thrombosis Recurrence After Catheter-Related Upper Extremity Deep Venous Thrombosis in Cancer Patients: A Retrospective Analysis. 癌症患者导管引起的上肢深静脉血栓后的静脉血栓复发：回顾性分析

IF 2.8 3区医学

Angiology Pub Date : 2024-08-01 Epub Date: 2023-05-17 DOI: 10.1177/00033197231176985

Rabiaa Hakem, Simon Soudet, Momar Diouf, Marie Antoinette Sevestre

{"title":"Venous Thrombosis Recurrence After Catheter-Related Upper Extremity Deep Venous Thrombosis in Cancer Patients: A Retrospective Analysis.","authors":"Rabiaa Hakem, Simon Soudet, Momar Diouf, Marie Antoinette Sevestre","doi":"10.1177/00033197231176985","DOIUrl":"10.1177/00033197231176985","url":null,"abstract":"Long-term indwelling central venous catheters (CVC) are frequently used to secure vascular access to deliver injectable treatment. Catheter-related thrombosis (CRT) occurs in approximately 2-6% of cancer patients. We conducted a single-center retrospective study to assess the rate of venous thromboembolism (VTE) recurrence in cancer patients; 200 patients were included. Mean age was 56 ± 15.15 years, median follow-up duration was 16.5 [range: 10-36] months. The incidence of recurrence was estimated using Gray's method for competing risk with death as the competing event of VTE. Recurrent VTE occurred in 25.5% of patients with a median occurrence time of 6.5 [range: 5-11.25] months. In case of recurrence, 94.6% of patients were treated for cancer and 80.4% of them received anticoagulants; 4 major bleeds and 17 non-major bleeds occurred during follow-up. In multivariate analysis, previous VTE (Hazard Ratio (HR) 2.48 (95% CI 1.42-4.32) and presence of CVC (HR 5.56 (95% CI 1.96-15.75) were significant recurrence risk factors. After a first episode of CRT, 25.5% of patients experienced VTE recurrence as UEDVT in 30 cases (55.5%), PE in 17 cases (31.5%), and DVT in 7 cases (13%), mostly during anticoagulation therapy. Anticoagulation therapy does not avoid CRT in case of cancer and must be balanced with hemorrhagic risk.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9531400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Reply Letter to: Carotid Artery Stenosis as a Predictor for Stroke Following Transcatheter Aortic Valve Implantation. 回信：颈动脉狭窄是经导管主动脉瓣植入术后脑卒中的预测因素。

IF 2.6 3区医学

Angiology Pub Date : 2024-07-23 DOI: 10.1177/00033197241265252

Atsushi Sugiura, Leonard Taube, Arthur Hartmann, Christian Schaefer, Marwan Hamiko, Sebastian Zimmer, Georg Nickenig, Nadjib Schahab

引用次数: 0

Letter: Inflammatory Markers and Coronary Collateral Circulation. 信：炎症标志物与冠状动脉侧支循环

IF 2.6 3区医学

Angiology Pub Date : 2024-07-22 DOI: 10.1177/00033197241267349

Aykut Demirkıran, Cihan Aydın, Mesut Engin

引用次数: 0

Letter: Sociodemographic/Environmental Determinants of Health Associated With Stroke and Mental Disorders. 信：与中风和精神障碍相关的社会人口/环境健康决定因素。